Usually overexpression of TRPM4 was reported in several types of malignancies, such as prostate cancer [183,184]; breast, cervical, and endometrial cancer [16,185,186,187]; diffuse large B cell lymphoma [188,189]; and acute myeloid leukemia [190]. This evidence concerns the gene TRPM4 and prostate cancer.